Tex. Occ. Code § 562.153 · Subchapter D. COMPOUNDED AND PREPACKAGED DRUGS
REQUIREMENTS FOR OFFICE USE COMPOUNDING.
Text — Current through the 89th 2nd Called Legislative Session, 2025
To dispense and deliver a compounded drug under Section 562.152, a pharmacy must:
(1) verify the source of the raw materials to be used in a compounded drug;
(2) comply with applicable United States Pharmacopoeia guidelines, including the testing requirements, and the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191);
(3) comply with all applicable competency and accrediting standards as determined by the board; and
(4) comply with board rules, including rules regarding the reporting of adverse events by practitioners and recall procedures for compounded products.
Notes and commentary — not statutory text
History
Amended by:
Acts 2005, 79th Leg., Ch. 28 (S.B. 492), Sec. 4, eff. September 1, 2005.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/OC/htm/OC.562.htm
- Text hash
- sha256 7e55add852173f7e34b29597f7bce1220706a8c1118b088827331f34a0cd9516
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
This section cites
Provisions in this library that the text above cites, as it prints each citation. A range cited as “ss. 61.13-61.16” links its first and last provisions.
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.